COST NO FEE

DUKE UNIVERSITY - PHARMACOKINETIC AND SAFETY OF ANTIRETROVIRAL AND RELATED DRUGS LACTATING WOMEN AND BREASTFED INFANTS STUDY

PIID: 75N94020F00002
Signed Date: Jan 28, 2026Effective Date: Sep 28, 2020End Date: Closed on Jun 30, 2026
Award $
$686K
Vendor
DUKE UNIVERSITY
NAICS
541715
Signed Date
Jan 28, 2026

Key Details

Dollars Obligated
$685,624
Base & All Options
Awarding Sub-Agency
National Institutes of Health
Product Service Code
AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
DURHAM, NC, 277054677, CD-NC-04

Description

PHARMACOKINETIC AND SAFETY OF ANTIRETROVIRAL AND RELATED DRUGS LACTATING WOMEN AND BREASTFED INFANTS STUDY

Context & Analysis

On Jan 28, 2026, Department of Health and Human Services obligated $685,624 to DUKE UNIVERSITY for pharmacokinetic and safety of antiretroviral and related drugs lactating women and breastfed infants study. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition. Performance is located in DURHAM, NC.

Contractor Information

Contractor: DUKE UNIVERSITY
UEI: TP7EK8DZV6N5
CAGE Code: 4B478
Location: DURHAM, NC
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related